Keyphrases
Orally Active
100%
Human Ovarian Cancer
100%
Inhibitor of Apoptosis Proteins
100%
Multiple Inhibitors
100%
AT-406
100%
Carboplatin
33%
Ovarian Cancer Cells
16%
Anti-apoptotic Proteins
8%
CIAP1
8%
Mechanism of Action
8%
Therapeutic Potential
8%
Induced Apoptosis
8%
Therapeutic Efficacy
8%
Protein Function
8%
Novel Therapies
8%
Cancer Cell Death
8%
Preclinical Animal Models
8%
Ovarian Cancer Patients
8%
Gynecologic Malignancies
8%
Human Ovarian Cancer Cell
8%
Ovarian Carcinoma
8%
Agent Behavior
8%
Therapeutic Mechanism
8%
Family Play
8%
Chemoresistance
8%
Ovarian Cancer Progression
8%
Platinum Therapy
8%
Anti-ovarian Cancer
8%
Acquired Platinum Resistance
8%
Medicine and Dentistry
Ovarian Cancer
100%
Inhibitor of Apoptosis Protein
100%
Carboplatin
66%
Cancer Cell
33%
Cell Line
33%
Ovarian Cancer Cell Line
16%
Cell Death
16%
Cancer
16%
Programmed Cell Death
16%
Combination Therapy
16%
In Vitro
16%
Drug Resistance
16%
Antiapoptotic
16%
Antiinfective Agent
16%
Krukenberg Tumor
16%
Protein Family
16%
Diseases
16%
Protein Function
16%
Biochemistry, Genetics and Molecular Biology
Inhibitor of Apoptosis
100%
Cancer Cell
75%
Cell Death
25%
Drug Resistance
25%
Protein Family
25%
Protein Function
25%
X-Linked Inhibitory Apoptosis Protein
25%
In Vivo Study
25%
Experimental Mouse
25%
Programmed Cell Death
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Inhibitor of Apoptosis Protein
100%
Carboplatin
57%
Antiapoptotic
14%
Antiinfective Agent
14%
Combination Therapy
14%
Ovary Carcinoma
14%
Drug Resistance
14%
Experimental Mouse
14%
Diseases
14%